Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $48.75 USD
Change Today -1.43 / -2.85%
Volume 2.2M
ISIS On Other Exchanges
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stanley T. Crooke M.D., Ph.D.

Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee,Isis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Stanley T. Crooke, M.D., Ph.D. has been an Executive Chairman of Isis Pharmaceuticals, Inc. since February 1991, and has been its Chief Executive Officer since January 1989. Dr. Crooke serves as the President of Isis Pharmaceuticals, Inc. He serves as an Editor-in-Chief of Current Opinion in Anticancer Drugs and Section Editor for Biologicals and Immunologicals for Expert Opinion on Investigational Drugs. Dr. Crooke founded Isis Pharmaceuticals, Inc. in 1989 and ...

Read Full Background

Corporate Headquarters*

2855 Gazelle Court
Carlsbad, California 92010

United States

Phone: 760-931-9200
Fax: --

Board Members Memberships*

Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee


Baylor College of Medicine
Baylor College of Medicine
Butler University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,488,488

Stock Options*

Restricted Stock Awards$1,489,375
All Other Compensation$18,986
Exercised Options160,000
Exercised Options Value$3,704,002
Exercisable Options370,699
Exercisable Options Value$18,922,332
Unexercisable Options288,443
Unexercisable Options Value$9,077,200
Total Value of Options$31,703,533
Total Number of Options819,142

Total Compensation*

Total Annual Cash Compensation$1,507,474
Total Short Term Compensation$1,488,488
Other Long Term Compensation$1,508,361
Total Calculated Compensation$6,228,143
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISIS:US $48.75 USD -1.43


Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Stephen R. Davis J.D.Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President
ACADIA Pharmaceuticals Inc.
John M. Maraganore M.D., Ph.D.Chief Executive Officer and Executive Director
Alnylam Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at